During March 1--April 30
* 1,918 suspected* cases were reported, including 286 probable and 97 confirmed cases.
* A total of 84 deaths were reported.
* A majority of case-reports were for hospitalized patients.
* 1,069 patients with suspected/probable cases for whom information was available
*755 were hospitalized
* the remaining 314 were examined in outpatient settings or emergency departments.
* Suspected or probable cases were reported from all 31 states and from the Federal District of Mexico.
* The four areas with the most cases were Federal District (213 cases), Guanajuato (141), Aguascalientes (93), and Durango (77).
* Suspected and probable cases were identified in all age groups.
Confirmed Cases
* 97 patientswere confirmed with laboratory-confirmed S--OIV infection
* 7 of those persons had died.
* The first of the 97 patients reported onset of illness (any symptom) on March 17, and the most recent patients reported onset on April 26.
Of the 24 patients for whom demographic and clinical information is available
* 20 (83%) were hospitalized, 3 were examined in outpatient settings, and 1 had illness that was not medically attended.
* Patients ranged in age from <1 to 59 years, with 79% aged 5 to 59 years; 15 (62%) patients were female.
* Patients with confirmed S-OIV infection were identified in four states: Federal District (15 cases), Mexico State (seven), Veracruz (one), Oaxaca (one).
* Of the 7 deaths, 6 occurred in Federal District, and 1 occurred in Oaxaca.
Among the 16 patients with complete clinical records
15 reported fever,
13 reported cough,
10 reported tachypnea, and
9 reported dyspnea. In addition,
7 reported either vomiting or diarrhea
8 were admitted to intensive-care units (of these)
7 required mechanical ventilation
6 subsequently died after developing acute respiratory distress syndrome
3 had underlying health conditions.
12 of 15 patients with radiography records available had confirmed pneumonia
Information on the duration of hospitalization before death was available for 6 patients and ranged from 1 to 18 days (median: 9 days).
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm58d0430a2.htm
* 1,918 suspected* cases were reported, including 286 probable and 97 confirmed cases.
* A total of 84 deaths were reported.
* A majority of case-reports were for hospitalized patients.
* 1,069 patients with suspected/probable cases for whom information was available
*755 were hospitalized
* the remaining 314 were examined in outpatient settings or emergency departments.
* Suspected or probable cases were reported from all 31 states and from the Federal District of Mexico.
* The four areas with the most cases were Federal District (213 cases), Guanajuato (141), Aguascalientes (93), and Durango (77).
* Suspected and probable cases were identified in all age groups.
Confirmed Cases
* 97 patientswere confirmed with laboratory-confirmed S--OIV infection
* 7 of those persons had died.
* The first of the 97 patients reported onset of illness (any symptom) on March 17, and the most recent patients reported onset on April 26.
Of the 24 patients for whom demographic and clinical information is available
* 20 (83%) were hospitalized, 3 were examined in outpatient settings, and 1 had illness that was not medically attended.
* Patients ranged in age from <1 to 59 years, with 79% aged 5 to 59 years; 15 (62%) patients were female.
* Patients with confirmed S-OIV infection were identified in four states: Federal District (15 cases), Mexico State (seven), Veracruz (one), Oaxaca (one).
* Of the 7 deaths, 6 occurred in Federal District, and 1 occurred in Oaxaca.
Among the 16 patients with complete clinical records
15 reported fever,
13 reported cough,
10 reported tachypnea, and
9 reported dyspnea. In addition,
7 reported either vomiting or diarrhea
8 were admitted to intensive-care units (of these)
7 required mechanical ventilation
6 subsequently died after developing acute respiratory distress syndrome
3 had underlying health conditions.
12 of 15 patients with radiography records available had confirmed pneumonia
Information on the duration of hospitalization before death was available for 6 patients and ranged from 1 to 18 days (median: 9 days).
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm58d0430a2.htm